| Message | Subject | Recs | Date/Time (ET) |
|
[i]The very rich have always been with us. Our Country is perhaps the best a | Biotech Valuation | | 01/08/2013 11:36:44 PM |
| > I have no reason not to believe my Thermodynamics professor
Well, I'm afrai | Biotech Valuation | | 09/22/2012 03:27:05 AM |
| > It's worth noting that their ROC looks significantly worse when they validated | Biotech Valuation | | 07/23/2012 11:57:20 PM |
|
The minimum grant you can instruct the fund to make on your behalf is $50. Th | Biotech Valuation | | 07/11/2012 01:09:24 AM |
| > I have some shares that are more than 10X and so I used a Fidelity Charitable | Biotech Valuation | | 07/10/2012 02:56:02 PM |
| I don't think there is any suggestion that treatment would be undertaken without | Biotech Valuation | | 05/22/2012 11:26:49 AM |
| I think that is a bogus example. He complains about his tax rate as a % of "tax | Biotech Valuation | 4 | 02/18/2012 02:57:00 PM |
| > Well I happen to be "AA" on rs2075650, so I'm pulling for that particular resu | Biotech Valuation | | 01/24/2012 02:56:52 AM |
| They did fix some things. It is still a bad paper with serious errors.
| Biotech Valuation | | 01/22/2012 03:42:08 AM |
| Ah well, I'll be racing you to the bottom :(
I'm somewhat consoled by the fac | 2011 Biotech Charity Contest | | 10/07/2011 01:22:24 PM |
| So, if 86% of unnecessary tests and prescriptions were for brand name statins, t | Biotech Valuation | | 10/03/2011 05:43:13 PM |
| > Gist of the article is more retractions which are taking longer to get resolv | Biotech Valuation | 2 | 08/11/2011 11:50:34 AM |
| Gosh. A couple hundred retractions per year, in all of science? I can't access | Biotech Valuation | 1 | 08/11/2011 01:42:41 AM |
| The 0.005 is because they've split their alpha between 0.045 for the primary end | Biotech Valuation | | 07/08/2011 08:14:13 PM |
| There should be a bar over the ".4", i.e. 0.4444...
| Biotech Valuation | | 06/22/2011 01:31:35 PM |
| Does SQNM have any patents that are relevant to a sequencing based assay? I kno | Sequenom, Inc. (SQNM) | | 03/22/2011 03:12:58 PM |
| <pre>
ARIA 20%
MNTA 20%
GNOM 20%
PACB 15%
ILM | 2011 Biotech Charity Contest | | 01/02/2011 03:11:30 PM |
| Ah well, it seems clear that rational argument is impossible.
A Toyota Prius | Biotech Valuation | 3 | 12/04/2010 03:36:46 AM |
| Sounds like a good start.
| Biotech Valuation | 1 | 12/03/2010 05:04:32 PM |
| <i>I have no reason to believe a professor lied, and I know the thermal efficien | Biotech Valuation | 2 | 12/03/2010 02:28:06 AM |
| Actually, "specificity" is defined as 1 - the false positive rate. So a specifi | Biotech Valuation | 2 | 09/30/2010 01:33:58 AM |
| I haven't seen the paper. But I would agree that a subgroup analysis can rule o | Biotech Valuation | 2 | 07/29/2010 01:47:40 AM |
| I doubt that Daniel saw my posts here; I think he would have said so if he did. | Biotech Valuation | 12 | 07/12/2010 03:13:44 PM |
| If I could, I probably wouldn't be hanging around here.
| Biotech Valuation | | 07/07/2010 03:59:46 PM |
| That was quick.
| Biotech Valuation | | 07/07/2010 12:52:46 PM |
| [duplicate post]
| Biotech Valuation | | 07/07/2010 12:47:31 PM |
| The QC they describe is for samples (call rate, IBD analysis, double enrollment, | Biotech Valuation | 1 | 07/04/2010 12:20:32 PM |
| The findings are certainly intriguing. I don't th | Biotech Valuation | 1 | 07/03/2010 02:24:08 PM |
| Actually you're wrong on both counts: the study is | Biotech Valuation | | 07/03/2010 01:31:15 PM |
| This study is 99% bogus. I'm not sure I'd dismiss the one SNP they found in APO | Biotech Valuation | 1 | 07/02/2010 09:23:41 PM |
| Well, the point of doing randomized clinical trials is that in general it is imp | Biotech Valuation | | 06/01/2010 10:53:33 PM |
| Gosh, what ever happened to the "new normal"?
| Biotech Valuation | | 03/28/2010 01:07:55 PM |
| Good luck with that. I'm still sitting on a 96+% profit on my short. I have to | SCO Group (SCOX) | | 02/13/2010 03:49:57 AM |
| Perlegen Ceases Operations
http://www.genomeweb.com/dxpgx/perlegen-ceases-ope | Perlegen | | 01/07/2010 04:43:19 PM |
| Was there something in particular that stuck out to you?
Seems like par for t | Biotech Valuation | 3 | 12/04/2009 02:11:32 PM |
| > a charge of $535 fr "surgery" appears on the insurance statement
Silly you, | Biotech Valuation | 1 | 11/20/2009 01:29:25 PM |
| TIPS are simpler to handle in tax advantaged accounts.
| Biotech Valuation | 1 | 08/07/2009 10:35:04 PM |
| Here is another new player:
http://www.trugenetics.com/
If you sign up now | Biotech Valuation | | 07/17/2009 03:53:12 PM |
| Clearly, detecting trace fetal RNA/DNA in maternal blood, the key issues are sen | biotech firesales | | 04/30/2009 01:32:06 PM |
| In the NY Times article, Dr Kraft is paraphrased as saying "any estimate of high | Biotech Valuation | | 04/16/2009 02:07:03 AM |
| But you don't get 1% of the gains either, right?
| Biotech Valuation | | 02/26/2009 11:36:16 PM |
| http://www.nature.com/nbt/journal/v27/n1/pdf/nbt0109-3.pdf
| Biotech Valuation | | 01/16/2009 02:21:09 AM |
| The question is whether the whole is more than the sum of the parts. If you hav | Biotech Valuation | | 01/09/2009 12:52:36 AM |
| Only the biomarker analysis. You can't easily interpret the P values they quote | Biotech Valuation | 1 | 01/08/2009 08:46:15 PM |
| This is what I'd found:
http://www.pgxhealth.com/news/pdf/VZ%20APA%20poster%2 | Biotech Valuation | | 01/08/2009 12:51:09 PM |
| > The impressive part of their .001 result was this was done without the benefit | Biotech Valuation | 1 | 01/08/2009 01:22:46 AM |
| So, what is the current Q ratio?
Is it 0.7, as this article says?
Or is it | Biotech Valuation | | 12/10/2008 11:31:50 PM |
| You're right, it isn't the inflation factor. It's just that the price on the se | Biotech Valuation | | 11/19/2008 02:51:22 AM |
| According to Fidelity, the inflation factor for that bond is 1.03566; that is su | Biotech Valuation | 1 | 11/18/2008 11:38:10 PM |
| There have been many recent discussions on the Bogleheads forums about TIPS: [ur | Biotech Valuation | | 11/03/2008 03:15:52 PM |
Copyright © 1995-2013 Knight Sac Media. All rights reserved.
